Printer Friendly

BIOMERICA RECEIVES INVESTMENT IN ITS SUBSIDIARY

 BIOMERICA RECEIVES INVESTMENT IN ITS SUBSIDIARY
 NEWPORT BEACH, Calif., Sept. 22 /PRNewswire/ -- Biomerica


(NASDAQ: BMRA) announced today that an investor group led by the Orange County, Calif.-based investment banking firm of A.M. Razo and Co., has purchased a 7 percent stake in Lancer Orthodontics Inc. (NASDAQ: LANZ), a Biomerica subsidiary. Final terms of the transaction were not disclosed.
 Lancer, a 25-year-old manufacturer of orthodontic appliances and supplies, indicated that funds from the stock sale will be used to fuel the earnings turnaround which has already begun and to allow Lancer to expand its orthodontics products base into other complementary dental products. Douglas Miller, Lancer president, formerly with Johnson and Johnson's orthodontic division, said, "We anticipate that the first quarter of 1993 (ended Aug. 31, 1992) will be profitable and will signal that we have turned the corner to continued profitability."
 Concerns about the transmission of the AIDS virus and other blood-born diseases have increased the demand for dental supplies by practitioners. Demand has increased for innovative dental supplies by dentists and orthodontists who need duplicate equipment and disposable supplies to eliminate the downtime caused by the more time consuming cleaning and disinfection procedures now required, according to Miller.
 Lancer Orthodontics Inc. is the only free-standing, NASDAQ-listed public company involved in the manufacture of orthodontic products and accessories. Biomerica is a medical company engaged in the development, manufacturing and marketing of advanced medical diagnostic products including home self-testing.
 -0- 9/22/92
 /CONTACT: Joseph Irani, president of Biomerica, 714-645-2111/
 (BMRA LANZ) CO: Biomerica; Lancer Orthodontics Inc.; A.M. Razo and Co. ST: California IN: MTC SU: TNM


KJ-JB -- LA011 -- 2009 09/22/92 08:52 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 22, 1992
Words:277
Previous Article:MEDCO RESEARCH'S ATP ANTICANCER DRUG MOVES TO CLINICAL TRIALS
Next Article:NYNEX MOBILE COMMUNICATIONS AND ROCHESTER TEL TO FORM CELLULAR SUPERSYSTEM IN UPSTATE NEW YORK
Topics:


Related Articles
BIOMERICA ANNOUNCES NEW FINANCING FOR LANCER ORTHODONTICS
BIOMERICA APPOINTS A NEW PRESIDENT FOR ITS LANCER ORTHODONTICS SUBSIDIARY
JURY INVALIDATES ORMCO PATENT FOR BIOMERICA SUBSIDIARY LANCER ORTHODONTICS
LANCER ORTHODONTICS INC. SELLS SEVEN PERCENT STAKE
BIOMERICA'S SUBSIDIARY ISSUED ALLERGY PATENT
BIOMERICA SUBSIDIARY RELEASES RESULTS OF LIPOSOME ALLERGY THERAPY STUDY
Biomerica Profits Exceed Expectations - Net Income Quadruples
Biomerica Reports Increased Net Profit for its Second Quarter
Biomerica Announces Year End Financial Results
Biomerica Announces Agreement to Purchase Remaining Interest In Lancer Orthodontics, Inc.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters